Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
86.89 USD | -1.14% | -1.24% | +13.95% |
22.05. | EDWARDS LIFESCIENCES CORPORATION : Citigroup gibt eine Kauf-Bewertung ab | ZM |
14.05. | EDWARDS LIFESCIENCES CORPORATION : Deutsche Bank Securities erhöht seine Kaufempfehlung | ZM |
ETFs investiert in Edwards Lifesciences Corporation
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,10% | 9 M€ | +9.41% | ||
0,09% | 571 M€ | +7.61% | - | |
0,09% | 0 M€ | 0.00% | - | |
0,08% | 1 166 M€ | +0.26% | - | |
0,08% | 607 M€ | +0.05% | - | |
0,08% | 34 M€ | +7.50% | - | |
0,07% | 391 M€ | +7.63% | - | |
0,06% | 306 M€ | +5.07% | - | |
0,06% | 39 M€ | +5.00% | - | |
0,06% | 7 M€ | +5.60% | - | |
0,06% | 32 M€ | +1.01% | - | |
0,06% | 17 M€ | +5.27% | - | |
0,05% | 15 M€ | -1.62% | - | |
0,04% | 17 M€ | +2.42% | - | |
0,04% | 9 M€ | +9.86% | - | |
0,04% | 17 M€ | +4.00% | - | |
0,03% | 105 M€ | +2.97% | - | |
0,03% | 6 M€ | +3.89% | ||
0,02% | 6 M€ | -4.26% | - | |
0,02% | 8 M€ | +0.25% | - | |
0,02% | 756 M€ | +0.05% | - | |
0,02% | 2 M€ | +3.16% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+13.95% | 52.36 Mrd. | |
+7.01% | 217 Mrd. | |
+11.01% | 190 Mrd. | |
+19.20% | 143 Mrd. | |
+30.79% | 111 Mrd. | |
+1.48% | 64.59 Mrd. | |
-0.16% | 48.45 Mrd. | |
-6.20% | 38.03 Mrd. | |
+0.91% | 35.6 Mrd. | |
+19.95% | 30.31 Mrd. |
- Börse
- Aktien
- 936853 Aktie
- ETFs Edwards Lifesciences Corporation